Showing results (91-100 of 1,016) with videos related to
Sort By:
Pageof 102
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2002
In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicinMothanje Barbara Lucia, Sergio Rutella, Giuseppe Leone, et al.BMC Immunology|August 29, 2009
Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cellsGiuseppina Bonanno, Andrea Mariotti, Annabella Procoli, et al.The Journal of Biological Chemistry|September 10, 2008
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptorsStefano Lancellotti, Sergio Rutella, Vincenzo De Filippis, et al.Expert Review of Molecular Diagnostics|September 21, 2017
Discovery and application of immune biomarkers for hematological malignanciesDimitrios Zafeiris, Jayakumar Vadakekolathu, Sarah Wagner, et al.Blood|May 16, 2013
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemiaAndrea Pession, Riccardo Masetti, Carmelo Rizzari, et al.Expert Review of Hematology|October 26, 2018
Current and future role of bispecific T-cell engagers in pediatric acute lymphoblastic leukemiaMattia Algeri, Francesca Del Bufalo, Federica Galaverna, et al.British Journal of Haematology|December 29, 2018
CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entityRiccardo Masetti, Salvatore N Bertuccio, Andrea Pession, et al.International Journal of Molecular Sciences|December 20, 2013
Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastomaAnna Alisi, William C Cho, Franco Locatelli, et al.Current Hematologic Malignancy Reports|February 27, 2019
Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic LeukemiaPietro Merli, Mattia Algeri, Francesca Del Bufalo, et al.Expert Review of Clinical Immunology|January 26, 2019
B-cell depleting immunotherapies: therapeutic opportunities and toxicitiesFrancesca Del Bufalo, Pietro Merli, Iside Alessi, et al.Pageof 102